Literature DB >> 14564312

Changing the model of care for patients with acute coronary syndromes.

Matthew T Roe1, E Magnus Ohman, Charles V Pollack, Eric D Peterson, Ralph G Brindis, Robert A Harrington, Robert H Christenson, Sidney C Smith, Robert M Califf, W Brian Gibler.   

Abstract

Acute coronary syndromes (ACS) represent a major cause of morbidity and mortality for patients with cardiovascular disease, but evidence-based therapies shown to improve outcomes for ACS are often underused in clinically eligible patients. Although clinical practice guidelines have been developed to provide standards for the diagnosis and treatment of patients with ACS and to provide physicians with a framework for clinical decision-making, multiple obstacles have hindered their implementation and questions remain about the applicability of guidelines for diverse clinical situations. Systematic reviews of quality-improvement studies have shown that multifaceted approaches using targeted educational interventions, creation of quality standards, and regular performance feedback are needed to ensure sustained improvements in care. Approaches to quality improvement thus are being redirected to focus on multidisciplinary collaborations designed to improve the entire process of care for patients with ACS. Multiple large observational registries and quality-improvement initiatives now are capturing data regarding adherence to practice guidelines and contemporary patterns of care for ACS. This comprehensive evaluation of ACS treatment will help guide efforts designed to promote evidence-based care and ultimately determine the effect of widespread implementation of practice guidelines on clinical outcomes. The shifting model of care for ACS therefore suggests that quality improvement and monitoring of adherence to practice guidelines should be considered components of optimal clinical practice.

Entities:  

Mesh:

Year:  2003        PMID: 14564312     DOI: 10.1016/S0002-8703(03)00388-0

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  6 in total

1.  The association of in-hospital major bleeding with short-, intermediate-, and long-term mortality among older patients with non-ST-segment elevation myocardial infarction.

Authors:  Renato D Lopes; Sumeet Subherwal; Dajuanicia N Holmes; Laine Thomas; Tracy Y Wang; Sunil V Rao; Erik Magnus Ohman; Matthew T Roe; Eric D Peterson; Karen P Alexander
Journal:  Eur Heart J       Date:  2012-03-05       Impact factor: 29.983

Review 2.  Platelet glycoprotein IIb/IIIa receptor antagonists in non-ST segment elevation acute coronary syndromes: a review and guide to patient selection.

Authors:  Brett D Atwater; Matthew T Roe; Kenneth W Mahaffey
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 3.  Current concepts in the antithrombotic management of non-ST-elevation acute coronary syndromes.

Authors:  David E Kandzari
Journal:  Curr Cardiol Rep       Date:  2004-07       Impact factor: 2.931

4.  Early treatment for non-ST-segment elevation acute coronary syndrome is associated with appropriate discharge care.

Authors:  Gregory J Fermann; Ali S Raja; Eric D Peterson; Matthew T Roe; James W Hoekstra; Sarah Milford-Beland; Deborah B Diercks; Charles V Pollack; W Frank Peacock; Richard Summers; E Magnus Ohman; W Brian Gibler
Journal:  Clin Cardiol       Date:  2009-09       Impact factor: 2.882

5.  Are patients with non-ST elevation myocardial infarction undertreated?

Authors:  Saman Rasoul; Jan Paul Ottervanger; Jan-Henk E Dambrink; Menko-Jan de Boer; Jan C A Hoorntje; A T Marcel Gosselink; Felix Zijlstra; Harry Suryapranata; Arnoud W J van 't Hof
Journal:  BMC Cardiovasc Disord       Date:  2007-03-05       Impact factor: 2.298

6.  Nine-year comparison of presentation and management of acute coronary syndromes in Ireland: a national cross-sectional survey.

Authors:  Frank Doyle; Davida De La Harpe; Hannah McGee; Emer Shelley; Ronán Conroy
Journal:  BMC Cardiovasc Disord       Date:  2005-02-11       Impact factor: 2.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.